PLX Financing Cash Flow
Protalix Biotherapeutics Inc · Financing Cash Flow
PLX Financing Cash Flow
Latest reported$0.00period ending
PLX Quarterly Cash from Financing ($0.00 → $0.00)
Quarterly financing cash flow
High-resolution chart · PNG
PLX financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 0 | |
| 150,000 | |
| 146,000 | |
| 0 | |
| 4,104,000 | |
| 5,076,000 | |
| 3,626,000 | |
| -20,420,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,433,000 | |
| 14,233,000 | |
| 4,075,000 | |
| 1,520,000 | |
| 2,643,000 | |
| 0 | |
| -4,046,000 | |
| -25,990,000 | |
| 0 | |
| 42,114,000 | |
| 4,652,000 | |
| 4,472,000 | |
| -1,264,000 | |
| 38,607,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -4,752,000 | |
| 0 | |
| -4,752,000 | |
| 0 | |
| -13,452,000 | |
| 9,542,000 | |
| -4,235,000 | |
| -6,726,000 | |
| 19,695,000 | |
| 0 | |
| 0 | |
| 0 | |
| 6,101,000 | |
| 0 | |
| 534,000 | |
| 0 | |
| 3,000 | |
| 12,000 | |
| 0 | |
| 31,000 | |
| -68,000 | |
| 66,930,000 | |
| 30,000 | |
| 0 | |
| 134,000 | |
| -140,000 | |
| 990,000 | |
| 25,574,000 | |
| 14,000 | |
| 4,000 | |
| -27,000 | |
| 20,936,000 | |
| 342,000 | |
| 132,000 | |
| 25,000 | |
| 2,000 | |
| 93,000 | |
| 192,000 | |
| 8,000 | |
| 0 | |
| 2,000 | |
| 0 | |
| -36,000 | |
| -17,000 | |
| 45,778,000 | |
| -83,000 | |
| 0 | |
| 12,871,000 | |
| 16,708,000 | |
| 0 | |
| 0 | |
| 0 | |
| 494,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |